Literature DB >> 21968694

Expanded role for interleukin-17 in rheumatoid arthritis.

Feng-Lai Yuan, Xia Li, Cheng-Wan Li, Rui-Sheng Xu, Jun-Ming Sun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21968694     DOI： 10.1007/s10067-011-1869-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  8 in total

1.  IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes.

Authors:  S Ryu; J H Lee; S I Kim
Journal:  Clin Rheumatol       Date:  2005-09-15       Impact factor: 2.980

2.  Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA.

Authors:  Siham Ali Metawi; Doaa Abbas; Manal Mohamed Kamal; Maha Khalil Ibrahim
Journal:  Clin Rheumatol       Date:  2011-03-29       Impact factor: 2.980

3.  Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.

Authors:  M Chabaud; J M Durand; N Buchs; F Fossiez; G Page; L Frappart; P Miossec
Journal:  Arthritis Rheum       Date:  1999-05

Review 4.  The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis.

Authors:  Xia Li; Feng-lai Yuan; Wei-guo Lu; Yi-qing Zhao; Cheng-wan Li; Jian-ping Li; Rui-sheng Xu
Journal:  Biochem Biophys Res Commun       Date:  2010-06-01       Impact factor: 3.575

Review 5.  Th17 cytokines and arthritis.

Authors:  Erik Lubberts
Journal:  Semin Immunopathol       Date:  2010-02-04       Impact factor: 9.623

Review 6.  The function of interleukin 17 in the pathogenesis of rheumatoid arthritis.

Authors:  Agnieszka Paradowska; Włodzimierz Maślińiski; Agnieszka Grzybowska-Kowalczyk; Jan Łacki
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Sep-Oct       Impact factor: 4.291

Review 7.  IL-17 as a future therapeutic target for rheumatoid arthritis.

Authors:  Wim B van den Berg; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

8.  Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.

Authors:  Ellen M Moran; Ronan Mullan; Jennifer McCormick; Mary Connolly; Owen Sullivan; Oliver Fitzgerald; Barry Bresnihan; Douglas J Veale; Ursula Fearon
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.